Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease with limited effective treatment options. The White Jade Snail Secretion (WJSS) is a biologically rich natural product with considerable therapeutic potential. UPLC–MS/MS analysis of WJSS against a standard compound spectral library and LC–MS/MS characterization of its purified protein fraction led to the identification of 88 small-molecule compounds and 782 peptide sequences, respectively. Network pharmacology analysis uncovered 240 common targets between WJSS and UC, enriched in key inflammatory pathways. A Dextran Sulfate Sodium (DSS)-induced mouse model of ulcerative colitis was employed to evaluate WJSS efficacy. WJSS treatment dose-dependently attenuated body weight loss, disease activity index elevation, and colon shortening, alongside significantly reduced histopathological scores. Mechanistically, WJSS suppressed NF-κB signaling, downregulating pro-inflammatory cytokines IL-6, TNF-α, and IL-1β. Furthermore, WJSS restored the expression of tight junction proteins (Occludin, ZO-1) and the mucin MUC2, thereby preserving intestinal barrier integrity. 16S rRNA sequencing revealed that WJSS reshaped the gut microbiota by enriching beneficial taxa (Unclassified-f-Lachnospiraceae) and reducing pathogenic taxa (Campylobacter, Helicobacter). Overall, WJSS alleviates DSS-induced UC through anti-inflammatory, barrier-protective, and microbiota-modulatory action, mediated by its peptides and small-molecule constituents. This study provides a multi-target mechanistic foundation for WJSS as a promising natural therapeutic candidate for UC, facilitating its clinical translation and natural product development.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: